Today, the United States Senate ignored the dietary supplement industry by continuing to move forward with crippling provisions left in the Food and Drug Administration Safety and Landmark Advancement Act (FDASLA).
NPA sent a letter to the Senate Committee on Health, Education, Labor and Pensions, urging the committee to drop dietary supplement provisions from the Safety and Landmark Advancement Act (FDASLA).
NPA issued the following statement in response to a study by the CDC about the use of Melatonin.
Rhode Island Senate Looks to Pass Legislation that Would Raise Vitamin Prices, Inconvenience Consumers, and Strain Retailers
Bill Would Require All Dietary Supplements to be Moved Behind the Counter, Unlike OTC Medicines
The NPA Awards salute industry pioneers and leaders for their accomplishments in science, environmental issues, advocacy, social responsibility, and the industry at large.